Baijin Life Science Holdings Ltd. is an investment company, which engages in the design, process, purchase, production, and distribution of pearl and jewellery products. The company employs 79 full-time employees The company went IPO on 2014-10-17. The firm operates the business through five segments. The Sales of Pearls and Jewellery Products segment is engaged in the design and sale of jewellery products as well as sale of pearls. The Brand marketing and Consulting Services segment is engaged in the provision of brand marketing and consulting services based on contracts with agreed terms of services. The Skincare Solutions Business segment is engaged in the sales of skincare solution products to cosmetic stores and hospitals by sales contracts as well as individuals via online sales platforms, under the brand name FO. The Research and Development Services segment is engaged in the Provision of professional scientific services. The Strategic Investment and Financial Services segment is engaged in the real estate financial assets investment.
Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
03/31/2025
03/31/2024
03/31/2023
03/31/2022
03/31/2021
Revenus
119
135
53
86
62
43
Croissance des revenus (H/H)
20%
155%
-38%
39%
44%
-61%
Coût des ventes
86
93
35
79
51
51
Bénéfice brut
33
41
18
7
10
-8
Vente, Général et Administration
36
35
30
-3
21
34
Recherche et développement
--
--
--
--
--
--
Frais d'exploitation
33
27
27
-4
21
39
Autres revenus (charges) non opérationnels
--
--
--
--
--
--
Bénéfice avant impôts
0
-1
-8
8
-15
-52
Charge d'impôt sur le revenu
-3
-1
0
0
0
0
Bénéfice net
8
0
-7
8
-15
-51
Croissance du bénéfice net
-173%
-100%
-188%
-153%
-71%
-82%
Actions en circulation (diluées)
772.39
693.89
644.99
603.39
372.93
235.91
Variation des actions (H-H)
14%
8%
7%
62%
57.99%
24%
EPS (dilué)
0.01
0
-0.01
0.01
-0.04
-0.21
Croissance du EPS
-166%
-96%
-181%
-135%
-81%
-85%
Flux de trésorerie libre
-20
-32
-6
-21
1
-16
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
27.73%
30.37%
33.96%
8.13%
16.12%
-18.6%
Marge opérationnelle
0%
10.37%
-16.98%
13.95%
-16.12%
-111.62%
Marge bénéficiaire
6.72%
0%
-13.2%
9.3%
-24.19%
-118.6%
Marge du flux de trésorerie libre
-16.8%
-23.7%
-11.32%
-24.41%
1.61%
-37.2%
EBITDA
6
20
-8
13
-9
-46
Marge EBITDA
5.04%
14.81%
-15.09%
15.11%
-14.51%
-106.97%
D&A pour le résultat opérationnel
6
6
1
1
1
2
EBIT
0
14
-9
12
-10
-48
Marge EBIT
0%
10.37%
-16.98%
13.95%
-16.12%
-111.62%
Taux d'imposition effectif
0%
100%
0%
0%
0%
0%
Follow-Up Questions
Baijin Life Science Holdings Limited 的關鍵財務報表是什麼?
根據最新的財務報表(Form-10K),Baijin Life Science Holdings Limited 的總資產為 $0,淨isProfitable}為 $0
MNNGF 的關鍵財務比率是什麼?
Baijin Life Science Holdings Limited 的流動比率為 0,淨利潤率為 0,每股銷售為 $0.19。
Baijin Life Science Holdings Limited 的收入按細分市場或地理位置如何劃分?
Le segment de revenus le plus important est Baijin Life Science Holdings Limited, avec un chiffre d'affaires de Jewellery lors du dernier rapport de résultats. En termes géographiques, United States est le marché principal pour Baijin Life Science Holdings Limited, avec un chiffre d'affaires de 68,774,000.
Baijin Life Science Holdings Limited 是否盈利?
non,根據最新的財務報表,Baijin Life Science Holdings Limited 的淨perte為 $0